Chronic Kidney Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chronic Kidney Disease stocks.

Chronic Kidney Disease Stocks Recent News

Date Stock Title
May 2 ARDX Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates
May 2 ARDX Ardelyx up 13% on quarterly results beat
May 2 ARDX Ardelyx GAAP EPS of -$0.11 beats by $0.04, revenue of $46.02M beats by $9.63M
May 2 ARDX Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
May 2 SNY Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
May 2 AKBA Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights
May 2 LSTA Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024
May 2 SNY 3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
May 2 AZN CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial
May 2 SNY Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations
May 1 ARDX Ardelyx Q1 2024 Earnings Preview
May 1 LSTA Lisata Therapeutics files for $150M mixed securities shelf
May 1 SNY Sanofi Q1: Wait And See For Now (Downgrade)
May 1 AZN AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases
May 1 ARDX Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
May 1 AZN AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio
Apr 30 SNY Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript
Apr 30 AZN Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
Apr 30 SNY Press Release: Annual General Meeting of April 30, 2024
Apr 30 SNY Sanofi: Q1 Earnings Reflect Growth And Strategic Acquisitions (Rating Upgrade)
Chronic Kidney Disease

Chronic kidney disease (CKD) is a type of kidney disease in which there is gradual loss of kidney function over a period of months or years. Early on there are typically no symptoms. Later, leg swelling, feeling tired, vomiting, loss of appetite, or confusion may develop. Complications may include heart disease, high blood pressure, bone disease, or anemia.Causes of chronic kidney disease include diabetes, high blood pressure, glomerulonephritis, and polycystic kidney disease. Risk factors include a family history of the condition. Diagnosis is generally by blood tests to measure the glomerular filtration rate and urine tests to measure albumin. Further tests such as an ultrasound or kidney biopsy may be done to determine the underlying cause. A number of different classification systems exist.Screening at-risk people is recommended. Initial treatments may include medications to manage blood pressure, blood sugar, and lower cholesterol. NSAIDs should be avoided. Other recommended measures include staying active and certain dietary changes. Severe disease may require hemodialysis, peritoneal dialysis, or a kidney transplant. Treatments for anemia and bone disease may also be required.Chronic kidney disease affected 753 million people globally in 2016, including 417 million females and 336 million males. In 2015 it resulted in 1.2 million deaths, up from 409,000 in 1990. The causes that contribute to the greatest number of deaths are high blood pressure at 550,000, followed by diabetes at 418,000, and glomerulonephritis at 238,000.

Browse All Tags